Indication
Congenital Hemolytic Anemia
1 clinical trial
2 products
Clinical trial
Nonmyeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease (SCD) and B-ThalassemiaStatus: Active (not recruiting), Estimated PCD: 2023-01-20
Product
AlemtuzumabProduct
Sirolimus